OpenSky billboard deemed sexist and offensive
Karabo Ledwaba
Subscribe & Follow
Trending
Advertise your job vacancies
Jobs
- Printed Carton Packaging Sales Representative Durban
- Senior Marketing Executive Cape Town
- WordPress Developer Cape Town
- Midweight Graphic and DTP Designer Stellenbosch
- HTML Email Designer Cape Town
- Language Practitioner Cape Town
- Sales Representative Midrand
- Business Manager Randburg
- Accounts Payable Clerk Cape Town
- Designer (Print & Graphic Specialist) Johannesburg
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.
